These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32485921)

  • 1. Effect of Proton Pump Inhibitors on Colorectal Cancer.
    Sasaki T; Mori S; Kishi S; Fujiwara-Tani R; Ohmori H; Nishiguchi Y; Hojo Y; Kawahara I; Nakashima C; Fujii K; Luo Y; Kuniyasu H
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxically augmented anti-tumorigenic action of proton pump inhibitor and GastrininAPCMin/+ intestinal polyposis model.
    Han YM; Hahm KB; Park JM; Hong SP; Kim EH
    Neoplasia; 2014 Jan; 16(1):73-83. PubMed ID: 24563620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of
    Fujiwara-Tani R; Fujii K; Mori S; Kishi S; Sasaki T; Ohmori H; Nakashima C; Kawahara I; Nishiguchi Y; Mori T; Sho M; Kondoh M; Luo Y; Kuniyasu H
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin.
    Han YM; Park JM; Kangwan N; Jeong M; Lee S; Cho JY; Ko WJ; Hahm KB
    J Physiol Pharmacol; 2015 Apr; 66(2):159-67. PubMed ID: 25903947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
    Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
    Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
    Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
    Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
    Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
    Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
    Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
    Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer.
    He J; Shi XY; Li ZM; Pan XH; Li ZL; Chen Y; Yan SJ; Xiao L
    BMC Mol Cell Biol; 2019 Nov; 20(1):49. PubMed ID: 31718559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses.
    Cao Y; Chen M; Tang D; Yan H; Ding X; Zhou F; Zhang M; Xu G; Zhang W; Zhang S; Zhuge Y; Wang L; Zou X
    Cell Death Dis; 2018 May; 9(6):604. PubMed ID: 29789637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.
    Robertson DJ; Larsson H; Friis S; Pedersen L; Baron JA; Sørensen HT
    Gastroenterology; 2007 Sep; 133(3):755-60. PubMed ID: 17678921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
    Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
    Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors and colorectal cancer: A systematic review.
    Patel A; Spychalski P; Antoszewska M; Regula J; Kobiela J
    World J Gastroenterol; 2021 Nov; 27(44):7716-7733. PubMed ID: 34908809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.